The Joint Council for Cosmetic Practitioners (JCCP) has released guidance intended to help registrants achieve and maintain compliance when advertising non-surgical cosmetic procedures. The guidance follows observations by the Professional
The Advertising Standards Authority (ASA) has upheld two complaints against Pharmacy Online over advertising for oral semaglutide weight-loss treatment. The ruling concerned Meta advertisements and website content published before and
The Advertising Standards Authority (ASA) held a virtual event bringing together regulators, advertisers and specialty leaders to explore health-related advertising concerns on October 1. Opening the event was ASA chair, baroness
The Joint Council for Cosmetic Practitioners (JCCP) has released guidance intended to help registrants achieve and maintain compliance when advertising non-surgical cosmetic procedures. The guidance follows observations by the Professional
The Advertising Standards Authority (ASA) has upheld a ruling against supplement company Kind Patches over an advert for its “GLP-1 Patch”. The paid-for Facebook ad, seen in March 2026, described
The Advertising Standards Authority (ASA) has banned beauty retailer Beauty Pie’s LED face mask advert for making misleading antiageing claims. The ASA shares that the advert, illustrated as a poster
The Advertising Standards Authority (ASA) has banned an advert promoting a skincare serum from skincare company Eucerin. The advert, which appeared on a billboard at Balham Tube station in London,
The Advertising Standards Authority (ASA) has published new research into how patients interpret weight-loss treatment advertisements. The findings show that, out of 2,030 participants, most believe weight-loss treatment advertisements can
The Advertising Standards Authority (ASA) has banned a series of social media advertisements promoting prescription-only weight-loss medicines (POMs) through affiliate and referral links. The organisation notes that these rulings mark
The Committee of Advertising Practice (CAP) contacted trade bodies and regulators to remind their members that promoting prescription-only medicines (POMs) is prohibited under both the advertising code and the law.
